Treatment of colon cancer with dendritic cells (DC) is one of the modern immunotherapy types. This is an opportunity to completely get rid of cancer or control the disease for a long time at an advanced stage.
Details →
Therapeutic radionuclides Lutetium-177-PSMA, Actinium-225-PSMA, and Radium-223 have been successfully used in the treatment of advanced prostate cancer.
Details →
A lung cancer vaccine is a modern opportunity to achieve cancer remission at any stage and reduce the risk of disease recurrence. The procedure is well tolerated and has practically no contraindications.
Details →
This treatment option is used for most cancers. Bladder cancer (BC) is one of the oncological diseases for which immunotherapy is highly effective.
Details →
The treatment of the fourth stage ovarian cancer is aimed at prolonging and improving the quality of life of patients and preventing or eliminating the development of complications.
Details →
Medulloblastoma, while most commonly associated with children, can also occur in adults, although it is much rarer. In adults, medulloblastoma accounts for less than 1% of all primary brain tumors
Details →
The main principle of this treatment is the restoration of the body's own defenses, the immune system, and nonspecific antitumor mechanisms.
Details →
Advances in treating lung cancer have led to improved survival rates, thereby extending the life expectancy of many cancer patients.
Details →
Dendritic cell therapy represents a transformative advancement in immunotherapy, redefining cancer treatment by empowering the immune system to precisely target malignant cells.
Details →
This is a common mechanism that provides cancer cells an escape from the innate immune system. Several therapeutics directed to CD47 or SIRPα have entered early clinical trials in recent years
Details →
Germany has become a global leader in cancer treatment, transforming many oncological diseases from terminal to manageable conditions.
Details →
Lung cancer is the most common group of malignant tumors in the world, which develops from cells in the lungs and bronchi. It develops 10% more often in men than in women.
Details →
Thyroid cancer is not the most common disease. More than 120,000 cases of thyroid cancer are diagnosed around the world every year, which is 1% of all malignant tumors.
Details →
Brain cancer is a group of malignant oncological pathologies when a tumour arises from the brain tissues or its membranes. Usually this is characterised by an unfavourable prognosis.
Details →
As global leaders in oncology research and treatment, German hospitals combine cutting-edge technologies with comprehensive patient care.
Details →
The Department of Oncology offers high-precision diagnostics and comprehensive treatment of oncological diseases, including palliative care for patients with terminal stages of malignancies.
Details →
Deteriorations in the liver function can be detected with the help of biochemical blood test. The following techniques help to diagnose liver cancer:
Details →
In Germany, prostate cancer is treated in large multidisciplinary university hospitals with urology and oncology departments, as well as specialized centers of prostate cancer treatment.
Details →
Cervical cancer is the second most common cancer among women under 45 years old. The most common cause of its development is human papillomavirus (HPV), due to which the tumor can appear at any age.
Details →
Our benefits:
.webp)
.webp)
 (1).webp)
 (1).webp)
